Safety, Tolerability, and Clinical Effects of Twice-daily Doses of Cinacalcet (AMG 073) in Adults With Primary Hyperparathyroidism (HPT)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Amgen
Related studies linked through entity extraction aliases.
A Novel Erythropoiesis Stimulating Protein (NESP; Darbopoetin Alfa) for the Treatment of Anemia in Lung Cancer Patients Receiving Multi-cycle Platinum-Containing Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
A Study of the Impact of Apremilast (CC-10004) on Quality of Life, Efficacy, and Safety in Adults With Manifestations of Plaque Psoriasis and Impaired Quality of Life
- Status
- COMPLETED
- Phase
- PHASE4
Safety, Pharmacokinetics, and Clinical Effects of Cinacalcet (AMG 073) in Primary Hyperparathyroidism
- Status
- COMPLETED
- Phase
- PHASE2
LCI-HEM-MYE-CRD-004 (MMRC-073 CARJAK): Study of CRD for Carfilzomib-Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Multiple Ascending Dose Study of AMG 598 in Adults With Obesity
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess Benefits of Apremilast in Patients With Moderate to Severe Chronic Plaque Psoriasis Followed by Dermatologists Under Real Life Settings in France
- Status
- COMPLETED
- Phase
- N/A
Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With High-Risk Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Blinatumomab Plus HLA-Mismatched Cellular Therapy for Relapsed/Refractory CD19+ ALL
- Status
- COMPLETED
- Phase
- PHASE1
Second-line FOLFIRI + Panitumumab in Subjects With Wild Type RAS Metastatic Colorectal
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy and Toxicity of Blinatumomab in the French ATU for Adult BCP-ALL R/R, or With MRD+ (FRENCH-CYTO)
- Status
- COMPLETED
- Phase
- N/A
Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.
- Status
- COMPLETED
- Phase
- PHASE4
Expanded Access for CC-10004
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy
- Status
- COMPLETED
- Phase
- PHASE3
Study of TVEC in Patients With Cutaneous Squamous Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma
- Status
- COMPLETED
- Phase
- PHASE3
A Study of CCX140-B in Subjects With Primary FSGS and Nephrotic Syndrome
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Biomarker Study of the Antitumoral Activity of Denosumab in the Pre- Operative Setting of Early Breast Cancer
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Effect of Evolocumab on Coronary Atherosclerosis
- Status
- COMPLETED
- Phase
- PHASE3